TY - JOUR T1 - Systematic review of the association between rotavirus infection, or rotavirus vaccination and coeliac disease JF - medRxiv DO - 10.1101/2020.12.01.20241869 SP - 2020.12.01.20241869 AU - Thomas Inns AU - Kate M Fleming AU - Miren Iturriza-Gomara AU - Daniel Hungerford Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/12/04/2020.12.01.20241869.abstract N2 - Background There is some evidence that rotavirus infection leads to an increased risk of coeliac disease (CD), and some immunological and biological plausibility for the human immune system recognising rotavirus particles and gluten proteins in a similar way. It is therefore plausible that rotavirus vaccine could have a role in preventing CD. However, such evidence has not previously been summarised in a systematic way to present a coherent picture. We conducted this systematic literature review to address this gap in the evidence. The aim of this research was to determine the nature of any association between rotavirus infection, or rotavirus vaccination, and risk of CD.Methods We searched Scopus, MEDLINE, Europe PMC and medRxiv for studies published between 01 January 1980 and 31 July 2020, using terms related to CD and rotavirus. Publications were screened independently by two reviewers using exclusion criteria. We extracted data from included papers using a standardized data extraction form and assessed risk of bias using the Newcastle-Ottawa Scale. Outcomes were descriptions of the settings and methods reported in included papers, and any estimates of effect.Results After exclusions, we reviewed five papers of which two used the exposure of rotavirus infection and three used the exposure of rotavirus vaccination. One paper found that rotavirus infection increased the risk of CD and that this was statistically significant. None of the three publications studying the association between rotavirus vaccination and CD were graded as high quality. All found a protective effect of RotaTeq® rotavirus vaccination, but this was only statistically significant in two studies.Conclusions Few studies have been published on this research question. Those that have been published are not of sufficient quality and did not use comparable methods. Due to differences in study results there remains uncertainty regarding the relationship between rotavirus infection, vaccination and CD.Competing Interest StatementDH has received research grant support on the topic of rotavirus vaccines from GlaxoSmithKline Biologicals, Sanofi Pasteur and Merck and Co (Kenilworth, New Jersey, US) after the closure of Sanofi Pasteur-MSD in December 2016. The other authors declare that they have no competing interests.Funding StatementDaniel Hungerford is funded by a National Institute for Health Research (NIHR) Post-doctoral Fellowship for this research project. Daniel Hungerford and Thomas Inns are affiliated to the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Gastrointestinal Infections at University of Liverpool in partnership with Public Health England (PHE), in collaboration with University of Warwick. Daniel Hungerford and Thomas Inns are based at the University of Liverpool. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health and Social Care or Public Health England.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated or analysed during this study are included in this published article.CDCoeliac DiseaseCIConfidence IntervalHLAHuman Leukocyte AntigenPRISMAPreferred Reporting Items for Systematic Reviews and Meta-AnalysesUKUnited Kingdom ER -